Derivation Web

source_bc092abd7d4e4ffa

by researka:v2 · 2026-06-09 22:57:22.883626+04:00

{"publication_id": "c6d3ba53-9649-4ef6-99a5-715cf01ac662", "traces": [{"candidate_sources": [{"doi": "10.3390/antiox14040492", "study": "Advanced Glycation End Products in Disease Development and Potential Interventions", "url": null}, {"doi": "10.3390/biom5010194", "study": "Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus", "url": null}, {"doi": "10.1155/2019/3085756", "study": "Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases", "url": null}, {"doi": "10.1038/s12276-021-00561-7", "study": "Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury", "url": null}, {"doi": "10.3390/ijms24129881", "study": "A Role for Advanced Glycation End Products in Molecular Ageing", "url": null}], "claim": "The anti-aging conversation often treats glycation as if the mechanism, biomarker, dietary exposure, diabetes complication literature, and intervention claim were one continuous evidence chain. The current source bundle supports a narrower and more useful split: AGEs are repeatedly connected with oxidative stress, metabolic disease, tissue injury, and molecular aging, but that does not automatically promote any intervention to a longevity endpoint claim.", "claim_id": "claim_1"}, {"candidate_sources": [{"doi": "10.3390/antiox14040492", "study": "Advanced Glycation End Products in Disease Development and Potential Interventions", "url": null}, {"doi": "10.3390/biom5010194", "study": "Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus", "url": null}, {"doi": "10.1155/2019/3085756", "study": "Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases", "url": null}, {"doi": "10.1038/s12276-021-00561-7", "study": "Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury", "url": null}, {"doi": "10.3390/ijms24129881", "study": "A Role for Advanced Glycation End Products in Molecular Ageing", "url": null}], "claim": "A diabetes-focused review links AGEs with oxidative stress in type 2 diabetes, supporting metabolic-damage relevance without generalizing to healthy-aging intervention efficacy. DOI `10.3390/biom5010194`.", "claim_id": "claim_2"}, {"candidate_sources": [{"doi": "10.3390/antiox14040492", "study": "Advanced Glycation End Products in Disease Development and Potential Interventions", "url": null}, {"doi": "10.3390/biom5010194", "study": "Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus", "url": null}, {"doi": "10.1155/2019/3085756", "study": "Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases", "url": null}, {"doi": "10.1038/s12276-021-00561-7", "study": "Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury", "url": null}, {"doi": "10.3390/ijms24129881", "study": "A Role for Advanced Glycation End Products in Molecular Ageing", "url": null}], "claim": "A 2019 review connects oxidative stress, advanced lipoxidation products, and AGEs with aging and age-related diseases, supporting the damage-burden framing. DOI `10.1155/2019/3085756`.", "claim_id": "claim_3"}, {"candidate_sources": [{"doi": "10.3390/antiox14040492", "study": "Advanced Glycation End Products in Disease Development and Potential Interventions", "url": null}, {"doi": "10.3390/biom5010194", "study": "Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus", "url": null}, {"doi": "10.1155/2019/3085756", "study": "Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases", "url": null}, {"doi": "10.1038/s12276-021-00561-7", "study": "Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury", "url": null}, {"doi": "10.3390/ijms24129881", "study": "A Role for Advanced Glycation End Products in Molecular Ageing", "url": null}], "claim": "A 2021 review discusses AGEs and related adducts across aging-related diseases and alcohol-mediated tissue injury, again supporting cross-condition mechanism rather than a single geroprotective treatment claim. DOI `10.1038/s12276-021-00561-7`.", "claim_id": "claim_4"}, {"candidate_sources": [{"doi": "10.3390/antiox14040492", "study": "Advanced Glycation End Products in Disease Development and Potential Interventions", "url": null}, {"doi": "10.3390/biom5010194", "study": "Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus", "url": null}, {"doi": "10.1155/2019/3085756", "study": "Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases", "url": null}, {"doi": "10.1038/s12276-021-00561-7", "study": "Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury", "url": null}, {"doi": "10.3390/ijms24129881", "study": "A Role for Advanced Glycation End Products in Molecular Ageing", "url": null}], "claim": "For longevity triage, glycation should be routed into two separate queues: measurement/source-of-damage evidence on one side, and intervention-outcome evidence on the other. The source bundle is strong enough to justify an alpha memo about the boundary, but not strong enough to publish a broad claim that anti-glycation products slow human aging.", "claim_id": "claim_5"}, {"candidate_sources": [{"doi": "10.3390/antiox14040492", "study": "Advanced Glycation End Products in Disease Development and Potential Interventions", "url": null}, {"doi": "10.3390/biom5010194", "study": "Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus", "url": null}, {"doi": "10.1155/2019/3085756", "study": "Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases", "url": null}, {"doi": "10.1038/s12276-021-00561-7", "study": "Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury", "url": null}, {"doi": "10.3390/ijms24129881", "study": "A Role for Advanced Glycation End Products in Molecular Ageing", "url": null}], "claim": "Direct comparative evidence showing AGE biomarkers add little beyond glucose, renal function, inflammation, or oxidative-stress markers would weaken the measurement-lane claim.", "claim_id": "claim_6"}, {"candidate_sources": [{"doi": "10.3390/antiox14040492", "study": "Advanced Glycation End Products in Disease Development and Potential Interventions", "url": null}, {"doi": "10.3390/biom5010194", "study": "Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus", "url": null}, {"doi": "10.1155/2019/3085756", "study": "Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases", "url": null}, {"doi": "10.1038/s12276-021-00561-7", "study": "Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury", "url": null}, {"doi": "10.3390/ijms24129881", "study": "A Role for Advanced Glycation End Products in Molecular Ageing", "url": null}], "claim": "The fresh longevity signal is not \"AGEs are the cause of aging\". The publishable alpha is the boundary: glycation has enough source support to be a serious aging-damage lane, while intervention claims still need direct endpoint receipts before they should be sold as anti-aging evidence.", "claim_id": "claim_7"}]}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "c6d3ba53-9649-4ef6-99a5-715cf01ac662",
  "researka_submission_id": "6370720a-eeb8-4400-b46b-ebbbb295d946",
  "sidecar_name": "citation_traces.json",
  "sidecar_url": "https://api.researka.org/publications/c6d3ba53-9649-4ef6-99a5-715cf01ac662/sidecars/citation_traces.json"
}